Marco Treven

Marco Treven

Auto-generated profile, based on publicly available information

Marco Treven

Department of Neurology, Medical Neuroscience Cluster, Medical University of Vienna, Vienna

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DKDaniel Knutson
Daniel Knutson
RKRevathi Kodali
Revathi Kodali
BDBranka Divović
Branka Divović
MTMarco Treven
Marco Treven
MSMichael Rajesh Stephen
Michael Rajesh Stephen
James CookJames Cook
James Cook

16 March 2015 in Epilepsia
Verified
Journal Article
Open access
PDF file
MTMarco Treven
Marco Treven
XKXaver König
Xaver König
EAElham Assadpour
Elham Assadpour
EGEnkhbileg Gantumur
Enkhbileg Gantumur
CMChristiane Meyer
Christiane Meyer
HKHelmut Kubista
Helmut Kubista
Summary: Objective: Within its range of therapeutic plasma concentrations, the anticonvulsant retigabine (ezogabine) is believed to selectively act on Kv7 channels. Here, the contribution of specific γ‐aminobutyric acid (GABA)Areceptor subtypes to the antiseizure effects of retigabine was investigated.Methods: Using patch‐clamp recordings, seizure‐like activity, tonic currents, andGABA‐induced currents in hippocampal neurons were tested for their sensitivity toward retigabine, as were recombinantGABAAreceptors expressed in tsA 201 cells.Results: Retigabine reduced seizure‐like activity elicited by low Mg2+in a concentration‐dependent manner with half maximal inhibition at 1 μm. Seizure‐like activity triggered by blocking either Kv7 channels orGABAAreceptors was equally reduced by retigabine, but when these channels/receptors were blocked simultaneously, the inhibition was lost. Retigabine (10 μm) enhanced bicuculline‐sensitive tonic currents in hippocampal neurons, but failed to affectGABA‐evoked currents. However, when receptors involved in phasicGABAergic inhibition were blocked by penicillin, retigabine did enhanceGABA‐evoked currents. In tsA 201 cells expressing various combinations ofGABAAreceptor subunits, 10 μmretigabine enhanced currents through α1β2δ, α4β2δ, α4β3δ, and α6β2δ receptors, but left currents through α1β2γ2S, α4β3γ2S, α5β3γ2S, and α6β2γ2S receptors unaltered. With αβ receptors, retigabine diminished currents through α1β2 and α4β3, but increased currents through α6β2 receptors. The enhancement of currents through α1β2δ receptors by retigabine was concentration dependent and became significant at 1 μm.Significance: These results demonstrate that retigabine is a subtype selective modulator ofGABAAreceptors with preference for extrasynaptic δ‐containing receptors; this property may contribute to its broad antiepileptic effectiveness and explain its lack of effect on absence seizures.

27 April 2016 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
GFGloria S. Forkuo
Gloria S. Forkuo
MGMargaret L. Guthrie
Margaret L. Guthrie
NYNina Y Yuan
Nina Y Yuan
ANAmanda N. Nieman
Amanda N. Nieman
RKRevathi Kodali
Revathi Kodali
Leggy ArnoldLeggy Arnold
Leggy Arnold

8 September 2022 in Frontiers in Psychology
Verified
Journal Article
Open access
BSBlanca T. M. Spee
Blanca T. M. Spee
RSRonald Sladky
Ronald Sladky
JFJoerg Fingerhut
Joerg Fingerhut
ALAlice Laciny
Alice Laciny
CKChristoph Kraus
Christoph Kraus
MTMarco Treven
Marco Treven
Recurrent, unvarying, and seemingly purposeless patterns of action and cognition are part of normal development, but also feature prominently in several neuropsychiatric conditions. Repetitive stereotyped behaviors (RSBs) can be viewed as exaggerated forms of learned habits and frequently correlate with alterations in motor, limbic, and associative basal ganglia circuits. However, it is still unclear how altered basal ganglia feedback signals actually relate to the phenomenological variability of RSBs. Why do behaviorally overlapping phenomena sometimes require different treatment approaches−for example, sensory shielding strategies versus exposure therapy for autism and obsessive-compulsive disorder, respectively? Certain clues may be found in recent models of basal ganglia function that extend well beyond action selection and motivational control, and have implications for sensorimotor integration, prediction, learning under uncertainty, as well as aesthetic learning. In this paper, we systematically compare three exemplary conditions with basal ganglia involvement, obsessive-compulsive disorder, Parkinson’s disease, and autism spectrum conditions, to gain a new understanding of RSBs. We integrate clinical observations and neuroanatomical and neurophysiological alterations with accounts employing the predictive processing framework. Based on this review, we suggest that basal ganglia feedback plays a central role in preconditioning cortical networks to anticipate self-generated, movement-related perception. In this way, basal ganglia feedback appears ideally situated to adjust the salience of sensory signals through precision weighting of (external) new sensory information, relative to the precision of (internal) predictions based on prior generated models. Accordingly, behavioral policies may preferentially rely on new data versus existing knowledge, in a spectrum spanning between novelty and stability. RSBs may then represent compensatory or reactive responses, respectively, at the opposite ends of this spectrum. This view places an important role of aesthetic learning on basal ganglia feedback, may account for observed changes in creativity and aesthetic experience in basal ganglia disorders, is empirically testable, and may inform creative art therapies in conditions characterized by stereotyped behaviors.

23 October 2023 in Tremor and Other Hyperkinetic Movements
Verified
Journal Article
Open access
PDF file
AHAdrian Handforth
Adrian Handforth
RSRam P. Singh
Ram P. Singh
MTMarco Treven
Marco Treven
MEMargot Ernst
Margot Ernst
Background: Prior work using GABAA receptor subunit knockouts and the harmaline model has indicated that low-dose alcohol, gaboxadol, and ganaxolone suppress tremor via α6βδ GABAA receptors. This suggests that drugs specifically enhancing the action of α6βδ or α6βγ2 GABAA receptors, both predominantly expressed on cerebellar granule cells, would be effective against tremor. We thus examined three drugs described by in vitro studies as selective α6βδ (ketamine) or α6βγ2 (Compound 6, flumazenil) receptor modulators. Methods: In the first step of evaluation, the maximal dose was sought at which 6/6 mice pass straight wire testing, a sensitive test for psychomotor impairment. Only non-impairing doses were used to evaluate for anti-tremor efficacy in the harmaline model, which was assessed in wildtype and α6 subunit knockout littermates. Results: Ketamine, in maximally tolerated doses of 2.0 and 3.5 mg/kg had minimal effect on harmaline tremor in both genotypes. Compound 6, at well-tolerated doses of 1–10 mg/kg, effectively suppressed tremor in both genotypes. Flumazenil suppressed tremor in wildtype mice at doses (0.015–0.05 mg/kg) far lower than those causing straight wire impairment, and did not suppress tremor in α6 knockout mice. Discussion: Modulators of α6βδ and α6βγ2 GABAA receptors warrant attention for novel therapies as they are anticipated to be effective and well-tolerated. Ketamine likely failed to attain α6βδ-active levels. Compound 6 is an attractive candidate, but further study is needed to clarify its mechanism of action. The flumazenil results provide proof of principle that targeting α6βγ2 receptors represents a worthy strategy for developing essential tremor therapies. Highlights We tested for harmaline tremor suppression drugs previously described as in vitro α6βδ or α6βγ2 GABAA receptor-selective modulators. Well-tolerated flumazenil doses suppressed tremor in α6-wildtype but not α6-knockout mice. Compound 6 and ketamine failed to display this profile, likely from off-target effects. Selective α6 modulators hold promise as tremor therapy.

22 September 2014 in Intrinsic Activity
Verified
Journal Article
Closed access
MTMarco Treven
Marco Treven